160 related articles for article (PubMed ID: 34720069)
1. Prognostic value of E-Cadherin and its tumor suppressor role in Saudi women with advanced epithelial ovarian cancer.
Assidi M; Jafri MA; Abu-Elmagd M; N Pushparaj P; Saddick S; Messaoudi S; Alkhatabi H; Al-Maghrabi J; Anfinan N; Sait M; El Omri A; Sait H; Basalamah H; Buhmeida A; Sait K
Libyan J Med; 2021 Dec; 16(1):1994741. PubMed ID: 34720069
[TBL] [Abstract][Full Text] [Related]
2. High N-Cadherin Protein Expression in Ovarian Cancer Predicts Poor Survival and Triggers Cell Invasion.
Assidi M
Front Oncol; 2022; 12():870820. PubMed ID: 35574323
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.
Rosso M; Majem B; Devis L; Lapyckyj L; Besso MJ; Llauradó M; Abascal MF; Matos ML; Lanau L; Castellví J; Sánchez JL; Pérez Benavente A; Gil-Moreno A; Reventós J; Santamaria Margalef A; Rigau M; Vazquez-Levin MH
PLoS One; 2017; 12(9):e0184439. PubMed ID: 28934230
[TBL] [Abstract][Full Text] [Related]
5. Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises.
Assidi M; Yahya FM; Al-Zahrani MH; Elkhatib R; Zari A; Elaimi A; Al-Maghrabi J; Dallol A; Buhmeida A; Abu-Elmagd M
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884678
[TBL] [Abstract][Full Text] [Related]
6. Expression and localization of e-cadherin in epithelial ovarian cancer.
Koensgen D; Freitag C; Klaman I; Dahl E; Mustea A; Chekerov R; Braicu I; Lichtenegger W; Sehouli J
Anticancer Res; 2010 Jul; 30(7):2525-30. PubMed ID: 20682978
[TBL] [Abstract][Full Text] [Related]
7. Role of SIX1, EYA2, and E-cadherin in ovarian carcinoma. Evidence on epithelial-mesenchymal transition from an immunohistochemical study.
Dawoud MM; Aiad HAES; Tawfiq EAE; Al-Qalashy FSA; Eissa N; El-Rebey HS
Ann Diagn Pathol; 2021 Dec; 55():151815. PubMed ID: 34534789
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
9. Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites-Correlation of tissue microarray and cytology microarray.
Toth L; Nagy B; Mehes G; Laszlo E; Molnar PP; Poka R; Hernadi Z
Pathol Res Pract; 2018 Jul; 214(7):978-985. PubMed ID: 29801775
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer.
Tian X; Han Y; Yu L; Luo B; Hu Z; Li X; Yang Z; Wang X; Huang W; Wang H; Zhang Q; Ma D
Cancer Biol Ther; 2017 Apr; 18(4):245-251. PubMed ID: 28346042
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of ADAM9 in ovarian cancer and its clinical significance.
Guo T; Yuan D; Lin M; Zhu D; Xu N; Wang J
J Clin Lab Anal; 2020 Apr; 34(4):e23136. PubMed ID: 31793719
[TBL] [Abstract][Full Text] [Related]
12. Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis.
Ryabtseva OD; Lukianova NY; Shmurakov YA; Polishchuk LZ; Antipova SV
Exp Oncol; 2013 Sep; 35(3):211-8. PubMed ID: 24084461
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma.
Shim HS; Yoon BS; Cho NH
Hum Pathol; 2009 May; 40(5):693-8. PubMed ID: 19157508
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.
Bačić B; Haller H; Mrklić I; Košta V; Čarić A; Tomić S
Arch Gynecol Obstet; 2013 Jun; 287(6):1219-24. PubMed ID: 23269354
[TBL] [Abstract][Full Text] [Related]
15. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
Yang M; Xie X; Ding Y
Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor 1 (
Han Y; Song C; Zhang T; Zhou Q; Zhang X; Wang J; Xu B; Zhang X; Liu X; Ying X
Cell Cycle; 2020 Oct; 19(20):2662-2675. PubMed ID: 32892698
[TBL] [Abstract][Full Text] [Related]
17. The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
Huang KJ; Sui LH
Med Oncol; 2012 Mar; 29(1):318-23. PubMed ID: 21264536
[TBL] [Abstract][Full Text] [Related]
18. [Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].
Lei SM; Liu X; Xia LP; Ke Y; Wei LW; Li L; Yin FJ
Zhonghua Fu Chan Ke Za Zhi; 2021 Jul; 56(7):489-497. PubMed ID: 34304441
[No Abstract] [Full Text] [Related]
19. Prognostic value of Osteopontin (SPP1) in colorectal carcinoma requires a personalized molecular approach.
Assidi M; Gomaa W; Jafri M; Hanbazazh M; Al-Ahwal M; Pushparaj P; Al-Harbi A; Al-Qahtani M; Buhmeida A; Al-Maghrabi J
Tumour Biol; 2019 Sep; 41(9):1010428319863627. PubMed ID: 31500540
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer.
Bodnar L; Stanczak A; Cierniak S; Smoter M; Cichowicz M; Kozlowski W; Szczylik C; Wieczorek M; Lamparska-Przybysz M
J Ovarian Res; 2014 Feb; 7():16. PubMed ID: 24499657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
